| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |